Valrubicin Market In Global
Valrubicin (CAS 56124-62-0) is a semisynthetic derivative of the antineoplastic anthracycline ant ... Read More
Baricitinib (CAS 1187594-09-7) is an orally bioavailable inhibitor of Janus kinases 1 and 2, with potential anti-inflammatory, immunomodulating and antineoplastic activities.
This report contains market size and forecasts of Baricitinib in global, including the following market information:
Global Baricitinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Baricitinib Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Baricitinib companies in 2021 (%)
The global Baricitinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Baricitinib include Bio-Techne, Selleck Chemicals, APExBIO Technology, TargetMol, Adooq Bioscience, Biorbyt, BioVision, Santa Cruz Biotechnology and Cayman Chemical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Baricitinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Baricitinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Baricitinib Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Baricitinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Baricitinib Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Baricitinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Baricitinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Baricitinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Baricitinib revenues share in global market, 2021 (%)
Key companies Baricitinib sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Baricitinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bio-Techne
Selleck Chemicals
APExBIO Technology
TargetMol
Adooq Bioscience
Biorbyt
BioVision
Santa Cruz Biotechnology
Cayman Chemical
Biosynth Carbosynth
Toronto Research Chemicals
BOC Sciences
Wuhan Sun-shine Bio-technology
Focus Biomolecules
AbMole
Clearsynth
Aladdin
Valrubicin (CAS 56124-62-0) is a semisynthetic derivative of the antineoplastic anthracycline ant ... Read More
Preladenant (CAS 377727-87-2) is a potent and selective antagonist at the adenosine A2A receptor. ... Read More
Monomethyl Fumarate (CAS 2756-87-8), the active metabolite of the psoriasis drug Fumaderm, is a p ... Read More
Acebilustat (CAS 943764-99-6), also known as ZK322, is a novel, oral, potent and selective leukot ... Read More